Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol. 2009;60:218–24. https://doi.org/10.1016/j.jaad.2008.09.022.
Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular risk in patients with psoriasis. J Am Coll Cardiol. 2021;77:1670–80. https://doi.org/10.1016/j.jacc.2021.02.009.
Article CAS PubMed PubMed Central Google Scholar
Armstrong EJ, Harskamp CT, Armstrong AW. Psoriasis and major adverse cardiovascular events: a systematic review and meta‐analysis of observational studies. J Am Heart Assoc. 2013;2:e000062. https://doi.org/10.1161/JAHA.113.000062.
Article PubMed PubMed Central Google Scholar
Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol. 2011;20:544–9. https://doi.org/10.1111/j.1600-0625.2011.01308.x.
Article CAS PubMed Google Scholar
Lockshin B, Balagula Y, Merola JF. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018;79:345–52. https://doi.org/10.1016/j.jaad.2018.02.040.
Article CAS PubMed Google Scholar
Yang K, Liu Q, Fan A, Lin H, Wang X, Cui T, et al. Th17 cells in cardiovascular disease. Cell Biochem Funct. 2025;43:e70069. https://doi.org/10.1002/cbf.70069.
Article CAS PubMed Google Scholar
Boehncke W-H, Boehncke S, Tobin A-M, Kirby B. The «psoriatic march»: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20:303–7. https://doi.org/10.1111/j.1600-0625.2011.01261.x.
Elnabawi YA, Dey AK, Goyal A, Groenendyk JW, Chung JH, Belur AD, et al. Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study. Cardiovasc Res. 2019;115:721–8. https://doi.org/10.1093/cvr/cvz009.
Article CAS PubMed PubMed Central Google Scholar
Bao W, Yang M, Xu Z, Yan F, Yang Q, Li X, et al. Coronary inflammation assessed by perivascular fat attenuation index in patients with psoriasis: a propensity score-matched study. Dermatology. 2022;238:562–70. https://doi.org/10.1159/000518771.
Article CAS PubMed Google Scholar
Piaserico S, Osto E, Famoso G, Montisci R, De Michieli L, Zanetti I, et al. Long-term prognostic value of coronary flow reserve in psoriasis patients. Atherosclerosis. 2019;289:57–63. https://doi.org/10.1016/j.atherosclerosis.2019.08.009.
Article CAS PubMed Google Scholar
Gröschel J, Grassow L, Blaszczyk E, Lommel K, Kokolakis G, Sabat R, et al. Deep cardiac phenotyping by cardiovascular magnetic resonance reveals subclinical focal and diffuse myocardial injury in patients with psoriasis (PSOR-COR study). Clin Res Cardiol. 2024. https://doi.org/10.1007/s00392-024-02456-9.
Article PubMed PubMed Central Google Scholar
Seremet S, Genc B, Tastan A, Akyildiz ZI, Nazli C, Ozcelik S, et al. Are all patients with psoriasis at increased risk for coronary artery disease? Int J Dermatol. 2015;54:355–61. https://doi.org/10.1111/ijd.12673.
Osto E, Piaserico S, Maddalozzo A, Forchetti G, Montisci R, Famoso G, et al. Impaired coronary flow reserve in young patients affected by severe psoriasis. Atherosclerosis. 2012;221:113–7. https://doi.org/10.1016/j.atherosclerosis.2011.12.015.
Article CAS PubMed Google Scholar
Tona F, Osto E, Kerkhof PLM, Montisci R, Famoso G, Lorenzoni G, et al. Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion. Eur J Clin Invest. 2022;52:e13711. https://doi.org/10.1111/eci.13711.
Article CAS PubMed Google Scholar
Kaiser H, Kvist-Hansen A, Krakauer M, Gørtz PM, Henningsen KMA, Wang X, et al. Statin therapy and vascular inflammation detected by positron emission tomography/computed tomography in patients with psoriasis. Acta Derm Venereol. 2021;101:adv00406. https://doi.org/10.2340/00015555-3752.
Green R, Cantoni V, Acampa W, Assante R, Zampella E, Nappi C, et al. Prognostic value of coronary flow reserve in patients with suspected or known coronary artery disease referred to PET myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2021;28:904–18. https://doi.org/10.1007/s12350-019-02000-7.
Levy BI, Heusch G, Camici PG. The many faces of myocardial ischaemia and angina. Cardiovasc Res. 2019;115:1460–70. https://doi.org/10.1093/cvr/cvz160.
Article CAS PubMed Google Scholar
Taqueti VR, Everett BM, Murthy VL, Gaber M, Foster CR, Hainer J, et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015;131:528–35. https://doi.org/10.1161/CIRCULATIONAHA.114.009716.
Article CAS PubMed Google Scholar
Britten MB, Zeiher AM, Schächinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis. 2004;15:259. https://doi.org/10.1097/01.mca.0000134590.99841.81.
Ikonomidis I, Makavos G, Papadavid E, Varoudi M, Andreadou I, Gravanis K, et al. Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation. Can J Cardiol. 2015;31:287–95. https://doi.org/10.1016/j.cjca.2014.11.002.
Ikonomidis I, Pavlidis G, Katogiannis K, Kapniari I, Theodoropoulos K, Kountouri A, et al. Differences in coronary flow reserve and flow-mediated dilation between plaque psoriasis and psoriatic arthritis. Eur Heart J. 2022;43:ehac544.2643. https://doi.org/10.1093/eurheartj/ehac544.2643.
Fioranelli M, Roccia MG, Lotti T. Coronary blood flow and psoriasis. Dermatol Ther. 2017. https://doi.org/10.1111/dth.12471.
Piaserico S, Osto E, Famoso G, Zanetti I, Gregori D, Poretto A, et al. Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis. Atherosclerosis. 2016;251:25–30. https://doi.org/10.1016/j.atherosclerosis.2016.05.036.
Article CAS PubMed Google Scholar
Piaserico S, Papadavid E, Cecere A, Orlando G, Theodoropoulos K, Katsimbri P, et al. Coronary microvascular dysfunction in asymptomatic patients with severe psoriasis. J Invest Dermatol. 2023;143:1929-1936.e2. https://doi.org/10.1016/j.jid.2023.02.037.
Article CAS PubMed Google Scholar
Jain H, Tariq MD, Khan AM, Ahsan A, Zulfiqar E, Shahnoor S, et al. Assessment of subclinical atherosclerosis in patients with psoriasis using echocardiographic coronary flow reserve parameters: a systematic review and meta-analysis. Br J Hosp Med. 2025;86(2):1–16. https://doi.org/10.12968/hmed.2024.0618.
Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve associates with adverse cardiovascular events independently of luminal angiographic severity, and modifies the effect of early revascularization. Circulation. 2015;131:19–27. https://doi.org/10.1161/CIRCULATIONAHA.114.011939.
Gullu H, Caliskan M, Dursun R, Ciftci O, Guven A, Muderrisoglu H. Impaired coronary microvascular function and its association with disease duration and inflammation in patients with psoriasis. Echocardiography. 2013;30:912–8. https://doi.org/10.1111/echo.12156.
Milaniuk S, Pietrzak A, Mosiewicz B, Mosiewicz J, Reich K. Influence of psoriasis on circulatory system function assessed in echocardiography. Arch Dermatol Res. 2015;307:855–61. https://doi.org/10.1007/s00403-015-1586-7.
Article PubMed PubMed Central Google Scholar
Gorga E, Scodro M, Valentini F, D’Ortona R, Arisi M, Sciatti E, et al. Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: a case–control study. Monaldi Arch Chest Dis Arch Monaldi Mal Torace. 2018;88:934.
Comments (0)